SV2002000502A - Nuevo procedimiento para la preparacion de pirazolopirimidinonas ref. pcs10384afae - Google Patents

Nuevo procedimiento para la preparacion de pirazolopirimidinonas ref. pcs10384afae

Info

Publication number
SV2002000502A
SV2002000502A SV2001000502A SV2001000502A SV2002000502A SV 2002000502 A SV2002000502 A SV 2002000502A SV 2001000502 A SV2001000502 A SV 2001000502A SV 2001000502 A SV2001000502 A SV 2001000502A SV 2002000502 A SV2002000502 A SV 2002000502A
Authority
SV
El Salvador
Prior art keywords
pirazolopirimidinonas
ref
preparation
new procedure
procedure
Prior art date
Application number
SV2001000502A
Other languages
English (en)
Inventor
Mark Edward Bunnage
Philip Charles Levett
Thomson Nicholas Murray
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2002000502(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015462A external-priority patent/GB0015462D0/en
Priority claimed from GB0105878A external-priority patent/GB0105878D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of SV2002000502A publication Critical patent/SV2002000502A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE PROPORCIONA UN PROCEDIMIENTO DE UN COMPUESTO DE FORMULA GENERAL I; VER FORMULA, EN LA QUE A, R1, R2, R3 Y R4 TIENEN LOS SIGNIFICADOS PROPORCIONADOS EN LA DESCRIPCION, PROCEDIMIENTO QUE COMPRENDE LA DESHIDROGENACION DE UN COMPUESTO DE FORMULA GENERAL II, VER FORMULA.
SV2001000502A 2000-06-22 2001-06-21 Nuevo procedimiento para la preparacion de pirazolopirimidinonas ref. pcs10384afae SV2002000502A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0015462A GB0015462D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105878A GB0105878D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazoloprimidinones

Publications (1)

Publication Number Publication Date
SV2002000502A true SV2002000502A (es) 2002-07-03

Family

ID=26244537

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000502A SV2002000502A (es) 2000-06-22 2001-06-21 Nuevo procedimiento para la preparacion de pirazolopirimidinonas ref. pcs10384afae

Country Status (26)

Country Link
EP (1) EP1296983B1 (es)
JP (1) JP2004501154A (es)
KR (1) KR100525699B1 (es)
AP (1) AP2001002195A0 (es)
AR (1) AR028729A1 (es)
AT (1) ATE282619T1 (es)
AU (2) AU6259201A (es)
BR (1) BR0111864A (es)
CA (1) CA2411957C (es)
CZ (1) CZ20024130A3 (es)
DE (1) DE60107248T2 (es)
ES (1) ES2231498T3 (es)
GT (2) GT200100113A (es)
HK (1) HK1079198A1 (es)
HU (1) HUP0301207A3 (es)
IL (1) IL152983A0 (es)
MX (1) MXPA02012887A (es)
MY (1) MY127737A (es)
PA (1) PA8520001A1 (es)
PE (1) PE20020091A1 (es)
PL (1) PL360299A1 (es)
PT (1) PT1296983E (es)
SV (1) SV2002000502A (es)
TN (1) TNSN01092A1 (es)
WO (1) WO2001098303A1 (es)
YU (1) YU84702A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
WO2000024745A1 (en) * 1998-10-23 2000-05-04 Pfizer Limited PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION

Also Published As

Publication number Publication date
HK1079198A1 (en) 2006-03-31
GT200100113AA (es) 2006-04-10
CZ20024130A3 (cs) 2004-01-14
PA8520001A1 (es) 2003-09-05
HUP0301207A2 (hu) 2003-08-28
BR0111864A (pt) 2003-07-01
PL360299A1 (en) 2004-09-06
JP2004501154A (ja) 2004-01-15
TNSN01092A1 (fr) 2005-11-10
ES2231498T3 (es) 2005-05-16
KR100525699B1 (ko) 2005-11-03
AP2001002195A0 (en) 2002-12-21
CA2411957C (en) 2007-09-18
DE60107248T2 (de) 2005-12-01
KR20030017556A (ko) 2003-03-03
AU6259201A (en) 2002-01-02
PT1296983E (pt) 2005-02-28
AU2001262592B2 (en) 2006-07-06
EP1296983B1 (en) 2004-11-17
CA2411957A1 (en) 2001-12-27
AR028729A1 (es) 2003-05-21
IL152983A0 (en) 2003-06-24
WO2001098303A1 (en) 2001-12-27
ATE282619T1 (de) 2004-12-15
MXPA02012887A (es) 2003-05-14
DE60107248D1 (de) 2004-12-23
PE20020091A1 (es) 2002-02-21
EP1296983A1 (en) 2003-04-02
HUP0301207A3 (en) 2006-02-28
YU84702A (sh) 2005-09-19
MY127737A (en) 2006-12-29
GT200100113A (es) 2002-06-04

Similar Documents

Publication Publication Date Title
HN2002000300A (es) Nuevos derivados de piperazina
NO20072142L (no) Mellomprodukter for fremstilling av heterocyklylalkylpiperidinderivater og forbindelser for fremstilling av disse
SV2003001172A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso ref. lea 35510-sv
DK1193270T3 (da) Pyrrolobenzodiazepiner
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
MXPA02012076A (es) Compuestos quimicos.
BR0114159A (pt) Herbicidas de fenilpropiniloxipiridina
HN2001000235A (es) Derivados puentes de piperazina
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
ECSP034813A (es) Arilsulfonamidas como agentes antivirales
CL2004000804A1 (es) Procedimiento de preparacion en una sola etapa de n-(n'-glicilo substituida)-2-cianopirrolidina.
BR0108046A (pt) Compostos azol condensados e seu uso como agentes hipoglicêmicos
DE60112960D1 (de) Kondensierte pyridoindolderivate
SV2002000503A (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas ref. pcs10383afae
SV1999000006A (es) Nuevas sulfonamidas naftil- y anilido-substituidas ref. lea 32809-sv
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
SV2002000502A (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas ref. pcs10384afae
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
UY28685A1 (es) Heterociclos con contenido de nitrógeno que afectan la transmisión sináptica glutamatérgica
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
BR0112600A (pt) Compostos calcilìticos
BR0110490A (pt) Agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina
AR028122A1 (es) Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
UY26718A1 (es) Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparación de un medicamento con efecto antagonista de n-metil-d-aspartato- (nmda)

Legal Events

Date Code Title Description
FD Lapse